Wedge Capital Management’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-173,083
Closed -$4.85M – 487
2023
Q3
$4.85M Buy
173,083
+12,624
+8% +$433K 0.1% 229
2023
Q2
$5.92M Sell
160,459
-20,319
-11% -$620K 0.09% 251
2023
Q1
$5.41M Sell
180,778
-36,444
-17% -$1.2M 0.09% 264
2022
Q4
$6.65M Buy
217,222
+29,005
+15% +$870K 0.11% 236
2022
Q3
$4.64M Buy
188,217
+15,592
+9% +$514K 0.08% 272
2022
Q2
$5.53M Buy
+172,625
New +$6.35M 0.09% 274

Other funds holding CC

Wedge Capital Management's CC Position: Q4 2023 in Review

Wedge Capital Management sold out of Chemours (CC) in Q4 2023, closing a stake of 173,083 shares — an estimated $4.85M sold.

Wedge Capital Management first reported a position in CC in Q2 2022 and held it in 6 quarters. The position peaked at $6.65M in Q4 2022. 469 funds tracked by Wall St. Rank hold CC as of Q4 2023.

  • Wedge Capital Management reported no remaining Chemours position as of Q4 2023 after selling out during the quarter.
  • Wedge Capital Management sold 173,083 Chemours shares in Q4 2023, an estimated $4.85M.
  • Wedge Capital Management first reported a position in Chemours in Q2 2022 and held it in 6 quarters.
  • Wedge Capital Management's Chemours position peaked at $6.65M in Q4 2022.
  • 469 funds tracked by Wall St. Rank held Chemours as of Q4 2023.

Based on Wedge Capital Management's 13F filing for Q4 2023, filed 1 Feb 2024.